ArticleFrontiers in pharmacology2021

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease.

Yuting Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.